CTRI/2025/04/084560尚未招募4 期
An open randomized clinical trial to evaluate the effect of Chirayata [Swertia purpurascens Wall]in the management of Non-Alcoholic Fatty Liver Disease
Prof Dr Vijay Chaudhary1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年8月20日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To lower the altered serum liver enzyme levels AST AND ALT.
研究概览
简要总结
At the end of trial collected data will be analyzed by using appropriate statistical methods.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients having altered serum liver enzymes levels defined as serum AST and ALT more than normal but less than 2 times upper normal limit and ultrasonographical evidence of Non -Alcoholic Fatty Liver Disease.
排除标准
- •Patients having serum liver level enzymes (AST and ALT)levels more than 2 times of upper normal limit .
- •Patients having hepatitis B and C ,liver malignancy or having any other comorbidity.
- •Patients consuming alcohol .
结局指标
主要结局
To lower the altered serum liver enzyme levels AST AND ALT.
时间窗: 3 months
次要结局
- To assess the clinical safety of Chirayata [Swertia purpurascens Wall]in the patients of Non-Alcoholic Fatty Liver Disease(12 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Clinical Study to Compare Two Skin Substitute Categories for Their Effectiveness to Treat Diabetic Foot UlcersDiabetic Foot UlcerNCT06557122Encoll Corp24
已完成
不适用
ODISEA Trauma: Parental Therapy Dispositive + Videofeedback 3.0Parent-Child RelationsParentingParent-child ProblemNCT04244318Esteban Gómez Muzzio153
招募中
1 期
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 SystemRecurrent Prostate CancerNCT03067051SpectraCure AB66
尚未招募
3 期
"It Is a Study to See Effectiveness Of Yavadi Kalka and Tiladi Kalka After Jaloukavacharana In The Management Of Dustavrana With Special Reference To Non Healing Traumatic Ulcer".CTRI/2022/10/046884BLDEAS AVS Ayurveda Mahavidyalaya40
已完成
不适用
Efficacy of the AkkoLens IOL in Patients With CataractCataractNCT06231784Vissum, Instituto Oftalmológico de Alicante25